Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P Value | Hazard ratio | 95% CI | P Value | |
Age (< 50 yr. vs. ≥50 yr.) | 1.535 | 0.688–3.422 | 0.295 | – | – | – |
Weight (< 60 kg vs. ≥60 kg) | 0.720 | 0.408–1.270 | 0.295 | – | – | – |
Tumour size (< 4 cm vs. ≥4 cm) | 1.322 | 0.745–2.347 | 0.340 | – | – | – |
Clinical Stage (I + II vs. III + IV) | 1.409 | 1.028–1.930 | 0.033* | 1.541 | 1.139–2.083 | 0.005* |
Histologicala grade (WD vs. MD + PD) | 3.659 | 1.641–8.162 | 0.002* | 3.316 | 1.462–7.524 | 0.004* |
Lymph Node (Neg. vs. Pos.) | 3.427 | 1.812–6.483 | < 0.0001* | 2.769 | 1.453–5.277 | 0.002* |
Menopause (Pre vs. Post) | 2.184 | 0.979–.4.870 | 0.056 | – | – | – |
ERb (Neg. vs. Pos.) | 0.843 | 0.476–1.491 | 0.557 | – | – | – |
PRc (Neg. vs. Pos.) | 0.717 | 0.380–1.356 | 0.306 | – | – | – |
Her-2d (Neg. vs. Pos.) | 1.784 | 0.999–3.184 | 0.050 | – | – | – |
TNBCe (No vs. Yes) | 0.839 | 0.450–1.563 | 0.579 | – | – | – |
Methylation (Meth. vs. Unmeth.) | 2.892 | 1.528–5.474 | 0.001* | 2.286 | 1.190–4.389 | 0.013* |